Dose-ranging Safety and Tolerability Study in Subjects ≥60 Years of Age

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
The study determined the safety of CNP520 in healthy elderly over 3 months. Data relevant for Pharmacokinetic/Pharmacodynamic modeling were obtained in order to define the target dose in subsequent efficacy studies.
Epistemonikos ID: abede46d6e76f0df6b6bfb66620142ba009e165a
First added on: May 12, 2024